Schafer: Medtronic’s $1B fumble could chill risk-taking

  • Article by: LEE SCHAFER , Star Tribune
  • Updated: January 23, 2014 - 8:56 PM

The recent collapse of Medtronic’s clinical trial for a blood pressure treatment device marks another watershed as the era of dynamic growth through invention comes to a close in the medi­cal device industry.

ADVERTISEMENT

Connect with twitterConnect with facebookConnect with Google+Connect with PinterestConnect with PinterestConnect with RssfeedConnect with email newsletters

ADVERTISEMENT

Advertisement
Golden Gavel by Star Tribune

Countdown to great deals

Bid Sept. 21-29

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT